Frankfurt am Main, Germany

Andreas Gille



 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Andreas Gille

Introduction

Andreas Gille is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of chemistry, particularly in the development of compounds that have potential applications in wound healing. With a total of 3 patents to his name, Gille continues to push the boundaries of innovation in his field.

Latest Patents

Gille's latest patents include the invention of heterocyclic carboxylic acid derivatives featuring a 2,5,7-substituted oxazolopyrimidine ring. This invention relates to oxazolopyrimidine compounds of formula (I), where A, R, R, R, R, X, and Y are defined as stated in the claims. The compounds of formula I are particularly suitable for applications in wound healing. Another significant patent involves 2,5,7-substituted oxazolopyrimidine derivatives, which also pertain to oxazolopyrimidine compounds of formula (I) with similar applications in wound healing.

Career Highlights

Andreas Gille is currently employed at Sanofi, a global healthcare company known for its commitment to innovation in pharmaceuticals. His work at Sanofi has allowed him to focus on developing new chemical compounds that can improve patient outcomes.

Collaborations

Gille has collaborated with several esteemed colleagues, including Dieter Kadereit and Matthias Schaefer. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Andreas Gille's contributions to the field of chemistry, particularly through his patents, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical applications, particularly in wound healing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…